(Q57622212)

English

Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques

article by Antti Saraste et al published 20 April 2012 in Journal of Nuclear Cardiology

In more languages

Statements

scholarly article

0 references

Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques (English)

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

Stephan G Nekolla

object named as

Stephan G. Nekolla

6

0 references

Markus Schwaiger

object named as

Markus Schwaiger

16

0 references

object named as

Juhani Knuuti

15

0 references

Seppo Ylä-Herttuala

object named as

Seppo Ylä-Herttuala

13

0 references

8

object named as

Irene Esposito

0 references

10

object named as

Pia Leppänen

0 references

3

object named as

Eliane Weidl

0 references

1

object named as

Antti Saraste

0 references

author name string

Iina Laitinen

2

0 references

Moritz Wildgruber

4

0 references

Axel W. Weber

5

0 references

Gabriele Hölzlwimmer

7

0 references

Axel Walch

9

0 references

Irina Lisinen

11

0 references

Peter B. Luppa

12

0 references

Hans-Jürgen Wester

14

0 references

publication date

20 April 2012

0 references

Journal of Nuclear Cardiology

0 references

19

0 references

4

0 references

775-784

0 references

https://scigraph.springernature.com/pub.10.1007/s12350-012-9554-5

0 references

Arithmetic of vulnerable plaques for noninvasive imaging

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Integrin-targeted imaging of inflammation in vascular remodeling

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipop

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12350-012-9554-5

21 January 2018

α v β 3 Integrin Expression in Normal and Atherosclerotic Artery

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Atherosclerotic Lesion Calcification in a Novel Mouse Model Combining Insulin Resistance, Hyperglycemia, and Hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12350-012-9554-5

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57622212&oldid=2116582629"